Black-white Differences in High Density Lipoproteins,Apolipoproteins,and Triglycerides: Relationships to Coronary Heart Disease in Non-uremic Populations and in Uremic Subjects Receiving Hemodialysis
Restricted accessEditorialFirst published online September, 1983
Black-white Differences in High Density Lipoproteins,Apolipoproteins,and Triglycerides: Relationships to Coronary Heart Disease in Non-uremic Populations and in Uremic Subjects Receiving Hemodialysis
StamlerJ., BerksonD.M., LindbergH.A., MillerW., HallY.: Racial patterns of coronary heart disease: blood pressure, body weight, and serum cholesterol in whites and negroes.Geriatrics,16, 382, 1961.
2.
KleinbaumD.G., KupperL.L., CasselJ.C., TyrolerH.A.: Multivariate analysis of risk of coronary heart disease in Evans County, Georgia.Arch. Intern. Med.128, 943, 1971.
3.
TyrolerH.A., HeydenS., BartelA..: Blood pressure and cholesterol as coronary heart disease risk factors.Arch. Inter. Med.128, 907, 1971.
4.
GillumR.F.: Coronary heart disease in black populations. I. Mortality and morbidity.Am. Heart J.104, 839, 1982; II. Coronary heart disease in black populations. II. Mortality and morbidity. Am. Heart J. 852, 1982.
5.
GillumR.F.: Pathophysiology of hypertension in blacks and whites.Hypertension1, 468, 1979.
6.
Five-year findings of the hypertension detection and follow-up program II.Mortality by race, sex and age.JAMA242, 2572, 1979.
7.
Weight and height of adults 18–74 years of age: United States, 1971–1974. U.S. vital and health statistics, Series 11, No. 211. DHEW Publ. No. (PHS) 79-1659, Washington, D.C., 1979, U.S. Government Printing Office, p. 3.
8.
LaskarzewskiP.M., KhouryP., KellyK., MelliesM.J., MorrisonJ.A., GlueckC.J.: Familial hypertriglyceridemia: The Princeton School District Family Study.Preventive Medicine11, 317, 1982.
9.
LaskarzewskiP.M., KhouryP., MorrisonJ.A., KellyK., MelliesM.J., GlueckC.J.: Prevalence of familial hyper- and hypolipoproteinemias: The Princeton School District Family Study.Metabolism31, 558, 1982.
10.
LaskarzewskyP.M., KhouryP., KellyK., MellesM.J., MorrisonJ.A., GlueckC.J.: Prevalence of familial hyper- and hypolipoproteinemias in blacks - The Princeton School District Study.Preventive Med.11, 142, 1982.
11.
CostasR.Jr., Garcia-PalmieriM.R., SorlieP., HertzmarkE.: Coronary heart disease risk factors in men with light and dark skin in Puerto Rico.Am. J. Public Health71, 614, 1981.
12.
KhouryP.R., MorrisonJ.A., LaskarzewskiP., KellyK., MelliesM.J., KingP., LarsonR., GlueckC.J.: Relationships of education and occupation to coronary heart disease risk factors in school children and adults: The Princeton School District Study.Am. J. Epidemiol.1113, 378, 1981.
13.
BerensonG.S., FosterT.A., FrankG.C.: Cardiovascular disease risk factor variables at the preschool age - The Bogalusa Heart Study.Circulation57, 603, 1978.
14.
GlueckC.J., KellyK., MelliesM.J., GartsideP.S., SteinerP.M.: Hypercholesterolemia and hyperalphalipoproteinemia in school children.Pediatrics62, 478, 1978.
15.
MorrisonJ.A., de GrootI., EdwardsB.K., KellyK.A., MelliesM.J., KhouryP., GlueckC.J.: Lipids and lipoproteins in 927 school children, ages 6 to 17 years.Pediatrics62, 990, 1978.
16.
MorrisonJ.A., deGrootI., KellyK.A.: Black-white differences in plasma lipids and lipoproteins in adults: The Cincinnati Lipid Research Clinic Population Study.Preventive Med.8, 34, 1979.
17.
MorrisonJ.A., KhouryP., MelliesM., KellyK., HowitzR., GlueckC.: Lipid and lipoprotein distribution in black adults: The Cincinnati Lipid Research Clinics Princeton School Study.JAMA245, 939, 1981.
18.
GordonT., CastelliW.P., HjortlandM.C., KannelW.B., DawberT.R.: High density lipoproteins as a protective factor against coronary hearth disease, Framingham Study.Am. J. Med.62, 707, 1977.
19.
MillerG.J., MillerN.E.: Plasma-high-density-lypoprotein concentration and development of ischemic heart disease.Lancet1, 16, 1975.
20.
GoldbergA.P., HarterH.R., PatschW., SchecktmanK.B., ProvinceM., WeertsC., KuiskI., McCrateM.M., SchonfeldG.: Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis.N. Engl. J. Med.308, 1245, 1983.
21.
FirstM.R., GlueckC.J.: Plasma lipids and coronary heart disease in renal failure.Int. J. Organs4, 120, 1981.
22.
GoldbergA.P., HagbergJ.M., Delmez HaynesM.E., HarterH.R.: Metabolic effect of exercise training in hemodialysis patients.Kidney Int.18, 754, 1980.
23.
ManninenV., MalkonenM., EisaloA.: Gemfibrozil treatment of dyslipidemias in renal failure with uraemia or in the nephrotic syndrome. Res. Clin.Forums4(#2), 113, 1982.